158 related articles for article (PubMed ID: 33062313)
1. Optical Coherence Tomography Parameters Related to Vision Impairment in Patients with Diabetic Macular Edema: A Quantitative Correlation Analysis.
Li B; Zhang B; Chen Y; Li D
J Ophthalmol; 2020; 2020():5639284. PubMed ID: 33062313
[TBL] [Abstract][Full Text] [Related]
2. Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment.
Tang L; Luo D; Qiu Q; Xu GT; Zhang J
Ophthalmic Res; 2023; 66(1):39-47. PubMed ID: 35697006
[TBL] [Abstract][Full Text] [Related]
3. Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular Edema.
Qin S; Zhang C; Qin H; Xie H; Luo D; Qiu Q; Liu K; Zhang J; Xu G; Zhang J
Front Physiol; 2021; 12():791442. PubMed ID: 35002773
[No Abstract] [Full Text] [Related]
4. Multifocal electroretinogram in diabetic macular edema and its correlation with different optical coherence tomography features.
Khojasteh H; Riazi-Esfahani H; Khalili Pour E; Faghihi H; Ghassemi F; Bazvand F; Mahmoudzadeh R; Salabati M; Mirghorbani M; Riazi Esfahani M
Int Ophthalmol; 2020 Mar; 40(3):571-581. PubMed ID: 31712927
[TBL] [Abstract][Full Text] [Related]
5. Hyperreflective foci as biomarkers for inflammation in diabetic macular edema: Retrospective analysis of treatment naïve eyes from south India.
Arthi M; Sindal MD; Rashmita R
Indian J Ophthalmol; 2021 May; 69(5):1197-1202. PubMed ID: 33913858
[TBL] [Abstract][Full Text] [Related]
6. Temporal variation of optical coherence tomography biomarkers as predictors of anti-VEGF treatment outcomes in diabetic macular edema.
Maggio E; Mete M; Sartore M; Bauci F; Guerriero M; Polito A; Pertile G
Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):807-815. PubMed ID: 34661731
[TBL] [Abstract][Full Text] [Related]
7. Automatic Segmentation of Retinal Fluid and Photoreceptor Layer from Optical Coherence Tomography Images of Diabetic Macular Edema Patients Using Deep Learning and Associations with Visual Acuity.
Hsu HY; Chou YB; Jheng YC; Kao ZK; Huang HY; Chen HR; Hwang DK; Chen SJ; Chiou SH; Wu YT
Biomedicines; 2022 May; 10(6):. PubMed ID: 35740291
[TBL] [Abstract][Full Text] [Related]
8. Validation of an Automated Artificial Intelligence Algorithm for the Quantification of Major OCT Parameters in Diabetic Macular Edema.
Midena E; Toto L; Frizziero L; Covello G; Torresin T; Midena G; Danieli L; Pilotto E; Figus M; Mariotti C; Lupidi M
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983137
[TBL] [Abstract][Full Text] [Related]
9. OCT-Based Biomarkers are Associated with Systemic Inflammation in Patients with Treatment-Naïve Diabetic Macular Edema.
Zhou J; Song S; Zhang Y; Jin K; Ye J
Ophthalmol Ther; 2022 Dec; 11(6):2153-2167. PubMed ID: 36166152
[TBL] [Abstract][Full Text] [Related]
10. Visual Acuity in Retinal Vein Occlusion, Diabetic, and Uveitic Macular Edema: Central Subfield Thickness and Ellipsoid Zone Analysis.
Ciulla TA; Kapik B; Grewal DS; Ip MS
Ophthalmol Retina; 2021 Jul; 5(7):633-647. PubMed ID: 33130256
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema].
Yang XL; Zou HD; Xu X
Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1081-8. PubMed ID: 24499694
[TBL] [Abstract][Full Text] [Related]
12. Assessment of serous macular detachment in eyes with diabetic macular edema by use of spectral-domain optical coherence tomography.
Koleva-Georgieva D; Sivkova N
Graefes Arch Clin Exp Ophthalmol; 2009 Nov; 247(11):1461-9. PubMed ID: 19547995
[TBL] [Abstract][Full Text] [Related]
13. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
[TBL] [Abstract][Full Text] [Related]
14. Aflibercept combined with triamcinolone acetonide in the treatment of diabetic macular edema: optical coherence tomography and optical coherence tomography angiography.
Li DS; Liao HX; Zhang CH; Huang JG; Chen W; Zhang JL; Qin B
Int J Ophthalmol; 2024; 17(4):670-675. PubMed ID: 38638246
[TBL] [Abstract][Full Text] [Related]
15. Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.
Yiu G; Welch RJ; Wang Y; Wang Z; Wang PW; Haskova Z
Ophthalmol Retina; 2020 Jan; 4(1):67-76. PubMed ID: 31669329
[TBL] [Abstract][Full Text] [Related]
16. Optical Coherence Tomography and Multifocal Electroretinography in Diabetic Macular Edema: A Neurovascular Relation With Vision.
Nagesh BN; Takkar B; Azad S; Azad R
Ophthalmic Surg Lasers Imaging Retina; 2016 Jul; 47(7):626-31. PubMed ID: 27434893
[TBL] [Abstract][Full Text] [Related]
17. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema After Dexamethasone Implants.
Huang YT; Chang YC; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Bair H; Lin JM; Chen WL; Tsai YY
Front Med (Lausanne); 2022; 9():852022. PubMed ID: 35755055
[TBL] [Abstract][Full Text] [Related]
18. Factors based on optical coherence tomography correlated with vision impairment in diabetic patients.
Endo H; Kase S; Tanaka H; Takahashi M; Katsuta S; Suzuki Y; Fujii M; Ishida S; Kase M
Sci Rep; 2021 Feb; 11(1):3004. PubMed ID: 33542264
[TBL] [Abstract][Full Text] [Related]
19. [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography].
Zhang Y; Yao J; Quan Y; Wang J; Xing Y; Zhou A
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1501-1508. PubMed ID: 34755665
[TBL] [Abstract][Full Text] [Related]
20. Spectral domain optical coherence tomography findings of patients with pars planitis and risk factors affecting visual acuity.
Yalçındağ FN; Temel E; Özgür EG
Int Ophthalmol; 2021 May; 41(5):1753-1761. PubMed ID: 33559832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
